{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:00:26Z","timestamp":1775840426950,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science Center, Poland","award":["2019\/35\/B\/NZ5\/01392"],"award-info":[{"award-number":["2019\/35\/B\/NZ5\/01392"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ceramide galactosyltransferase (UGT8) is overexpressed in basal-like breast cancer (BC) tumors and is associated with an increased risk of lung metastasis. UGT8 synthesizes galactosylceramide (GalCer), an anti-apoptotic molecule that promotes BC cell survival within the tumor microenvironment and enhances resistance to anticancer drugs. In this study, we aimed to elucidate the molecular mechanisms underlying UGT8 overexpression in BC cells.\n                    <jats:italic>UGT8<\/jats:italic>\n                    promoter constructs and deletion mutants were generated by PCR. Promoter activity was assessed using a dual-luciferase assay, and key regulatory sequences were identified by electrophoretic mobility shift assay (EMSA). Candidate transcription factors were predicted using the JASPAR database and validated by qPCR, Western blotting, and immunohistochemistry. GalCer levels were measured by thin-layer chromatography (TLC) binding assay, and LHX6\u2013DNA interactions were analyzed by surface plasmon resonance. Apoptotic cells were detected using the Thermo Dead Cell Apoptosis Kit.\n                    <jats:italic>UGT8<\/jats:italic>\n                    promoter activity was significantly higher in UGT8-positive MDA-MB-231 cells than in UGT8-negative T47D and MCF-7 cells, indicating that\n                    <jats:italic>UGT8<\/jats:italic>\n                    gene expression is regulated at the transcriptional level. Sequential promoter deletions combined with EMSA localized a key regulatory region (\u2212\u20091132 to\u2009\u2212\u20091618\u00a0bp), termed the UGT8 response element (UGT8RE). In silico analysis identified potential transcription factors, among which the LIM\/homeobox protein LHX6 was markedly upregulated in MDA-MB-231 cells. Site-directed mutagenesis of two predicted LHX6 binding sites (LHX6BS1 and LHX6BS2) demonstrated that LHX6BS2 is essential for UGT8 promoter activity. RNAi-mediated inhibition of LHX6 reduced UGT8 expression and GalCer synthesis, thereby sensitizing MDA-MB-231 cells to doxorubicin-induced apoptosis. The LIM\/homeobox protein LHX6 may regulate the UGT8 expression in BC cells. Targeting LHX6 decreases UGT8 expression and GalCer synthesis, thereby sensitizing MDA-MB-231 cells to doxorubicin. Given UGT8\u2019s role in cell survival and drug resistance, inhibition of LHX6 may represent a promising therapeutic strategy for drug-resistant BC.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-42260-1","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:14:59Z","timestamp":1772612099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["UGT8\/GalCer-dependent resistance of breast cancer cells to drug-induced apoptosis is potentially regulated by the LIM\/homeobox protein LHX6"],"prefix":"10.1038","volume":"16","author":[{"given":"Jaroslaw","family":"Suchanski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weronika","family":"Woldanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safoura","family":"Nour Ebad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Grzymajlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz B.","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Romanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Smolarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Dziegiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Ugorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"2","key":"42260_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/bi00830a008","volume":"8","author":"P Morell","year":"1969","unstructured":"Morell, P. & Radin, N. S. Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acid. Biochemistry 8(2), 506\u2013512 (1969).","journal-title":"Biochemistry"},{"issue":"40","key":"42260_CR2","doi-asserted-by":"publisher","first-page":"25880","DOI":"10.1074\/jbc.273.40.25880","volume":"273","author":"H Sprong","year":"1998","unstructured":"Sprong, H. et al. UDP-galactose: Ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum. J. Biol. Chem. 273(40), 25880\u201325888 (1998).","journal-title":"J. Biol. Chem."},{"key":"42260_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-4939-1154-7_12","volume":"9","author":"JM Boggs","year":"2014","unstructured":"Boggs, J. M. Role of galactosylceramide and sulfatide in oligodendrocytes and CNS myelin: Formation of a glycosynapse. Adv. Neurobiol. 9, 263\u2013291 (2014).","journal-title":"Adv. Neurobiol."},{"issue":"5","key":"42260_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<613::AID-JNR6>3.0.CO;2-V","volume":"54","author":"T Coetzee","year":"1998","unstructured":"Coetzee, T., Dupree, J. L. & Popko, B. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice. J. Neurosci. Res. 54(5), 613\u2013622 (1998).","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"42260_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1073\/pnas.012540899","volume":"99","author":"SI Hakomori","year":"2002","unstructured":"Hakomori, S. I. The glycosynapse. Proc. Natl. Acad. Sci. U. S. A. 99(1), 225\u2013232 (2002).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"42260_CR6","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1046\/j.1471-4159.1995.65052267.x","volume":"65","author":"N Schaeren-Wiemers","year":"1995","unstructured":"Schaeren-Wiemers, N., Vanderbijl, P. & Schwab, M. E. The UDP-galactose-ceramide galactosyltransferase - Expression pattern in oligodendrocytes and Schwann-cells during myelination and substrate preference for hydroxyceramide. J. Neurochem. 65(5), 2267\u20132278 (1995).","journal-title":"J. Neurochem."},{"issue":"4","key":"42260_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/sj.bjc.6605750","volume":"103","author":"P Dziegiel","year":"2010","unstructured":"Dziegiel, P. et al. Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases. Br. J. Cancer 103(4), 524\u2013531 (2010).","journal-title":"Br. J. Cancer"},{"key":"42260_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/5584_2016_69","volume":"952","author":"A Rzechonek","year":"2016","unstructured":"Rzechonek, A. et al. Expression of ceramide galactosyltransferase (UGT8) in primary and metastatic lung tissues of non-small-cell lung cancer. Adv. Exp. Med. Biol. 952, 51\u201358 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"42260_CR9","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1194\/jlr.M093955","volume":"60","author":"AM Lemay","year":"2019","unstructured":"Lemay, A. M. et al. High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma. J. Lipid Res. 60(10), 1776\u20131786 (2019).","journal-title":"J. Lipid Res."},{"key":"42260_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.712746","volume":"11","author":"Z Xiong","year":"2021","unstructured":"Xiong, Z. et al. Exploration of lipid metabolism in gastric cancer: A novel prognostic genes expression profile. Front. Oncol. 11, 11 (2021).","journal-title":"Front. Oncol."},{"issue":"9","key":"42260_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/sj.onc.1209165","volume":"25","author":"F Yang","year":"2006","unstructured":"Yang, F. et al. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways. Oncogene 25(9), 1413\u20131419 (2006).","journal-title":"Oncogene"},{"issue":"1","key":"42260_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-007-9836-9","volume":"112","author":"E Ruckhaberle","year":"2008","unstructured":"Ruckhaberle, E. et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 112(1), 41\u201352 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"42260_CR13","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00257","volume":"23","author":"SK Santuario-Facio","year":"2017","unstructured":"Santuario-Facio, S. K. et al. A new gene expression signature for triple-negative breast cancer using frozen fresh tissue before neoadjuvant chemotherapy. Mol. Med. 23, 23 (2017).","journal-title":"Mol. Med."},{"issue":"10\u201311","key":"42260_CR14","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1177\/0962280218794722","volume":"28","author":"P Segaert","year":"2019","unstructured":"Segaert, P., Lopes, M. B., Casimiro, S., Vinga, S. & Rousseeuw, P. J. Robust identification of target genes and outliers in triple-negative breast cancer data. Stat. Methods Med. Res. 28(10\u201311), 3042\u20133056 (2019).","journal-title":"Stat. Methods Med. Res."},{"issue":"18","key":"42260_CR15","doi-asserted-by":"publisher","first-page":"7480","DOI":"10.1158\/0008-5472.CAN-08-3350","volume":"69","author":"AC Culhane","year":"2009","unstructured":"Culhane, A. C. & Quackenbush, J. Confounding effects in \u201cA six-gene signature predicting breast cancer lung metastasis\u201d. Cancer Res. 69(18), 7480\u20137485 (2009).","journal-title":"Cancer Res."},{"issue":"15","key":"42260_CR16","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-08-0436","volume":"68","author":"T Landemaine","year":"2008","unstructured":"Landemaine, T. et al. A six-gene signature predicting breast cancer lung metastasis. Cancer Res. 68(15), 6092\u20136099 (2008).","journal-title":"Cancer Res."},{"issue":"24","key":"42260_CR17","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1158\/0008-5472.CAN-09-2688","volume":"69","author":"K Driouch","year":"2009","unstructured":"Driouch, K., Bonin, F., Sin, S., Clairac, G. & Lidereau, R. Confounding effects in \u201cA six-gene signature predicting breast cancer lung metastasis\u201d: Reply. Cancer Res. 69(24), 9507\u20139511 (2009).","journal-title":"Cancer Res."},{"issue":"12","key":"42260_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084191","volume":"8","author":"TB Owczarek","year":"2013","unstructured":"Owczarek, T. B. et al. Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule. PLoS ONE 8(12), e84191 (2013).","journal-title":"PLoS ONE"},{"issue":"1","key":"42260_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1058-z","volume":"20","author":"J Suchanski","year":"2018","unstructured":"Suchanski, J. et al. Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: A two-edged sword in breast cancer progression. Breast Cancer Res. 20(1), 133 (2018).","journal-title":"Breast Cancer Res."},{"issue":"2","key":"42260_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/cancers16020389","volume":"16","author":"J Suchanski","year":"2024","unstructured":"Suchanski, J. et al. Galactosylceramide upregulates the expression of the gene and downregulates the expression of and genes, acting as an anti-apoptotic molecule in breast cancer cells. Cancers 16(2), 389 (2024).","journal-title":"Cancers"},{"issue":"6","key":"42260_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<757::AID-JNR15>3.0.CO;2-W","volume":"52","author":"T Yonemasu","year":"1998","unstructured":"Yonemasu, T. et al. Proximal promoter region is sufficient to regulate tissue-specific expression of UDP-galactose: Ceramide galactosyltransferase gene. J. Neurosci. Res. 52(6), 757\u2013765 (1998).","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"42260_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0167-4781(00)00283-9","volume":"1517","author":"T Tencomnao","year":"2001","unstructured":"Tencomnao, T., Yu, R. K. & Kapitonov, D. Characterization of the human UDP-galactose:ceramide galactosyltransferase gene promoter. BBA Gene Struct. Expr. 1517(3), 416\u2013423 (2001).","journal-title":"BBA Gene Struct. Expr."},{"issue":"5","key":"42260_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1023\/B:GLYC.0000033630.58533.16","volume":"20","author":"T Tencomnao","year":"2003","unstructured":"Tencomnao, T., Kapitonov, D., Bieberich, E. & Yu, R. K. Transcriptional regulation of the human UDP-galactose:ceramide galactosyltransferase (hCGT) gene expression: Functional role of GC-box and CRE. Glycoconjugate J. 20(5), 339\u2013351 (2003).","journal-title":"Glycoconjugate J."},{"issue":"10","key":"42260_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/glycob\/cwu042","volume":"24","author":"K Okahara","year":"2014","unstructured":"Okahara, K. et al. Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2. Glycobiology 24(10), 926\u2013934 (2014).","journal-title":"Glycobiology"},{"key":"42260_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2021.11.099","volume":"587","author":"J Ji","year":"2022","unstructured":"Ji, J. et al. SOX9-mediated UGT8 expression promotes glycolysis and maintains the malignancy of non-small cell lung cancer. Biochem. Biophys. Res. Commun. 587, 139\u2013145 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"42260_CR26","volume-title":"WHO Classification of Tumours of the Breast","author":"S Lakhani","year":"2012","unstructured":"Lakhani, S., Ellis, I., Schnitt, S., Tan, P. & van de Vijver, M. WHO Classification of Tumours of the Breast 4th edn. (IARC Press, 2012).","edition":"4"},{"key":"42260_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411873","author":"J Suchanski","year":"2025","unstructured":"Suchanski, J., Woldanska, W., Sciana, A., Suchanska, B. & Moniakowski, L. Sulfatide acts as a regulatory molecule controlling \u03b21 Integrin-STAT5 signaling and BOLA2-dependent apoptotic pathway in breast cancer cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms262411873 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"42260_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01047850","volume":"6","author":"M Ugorski","year":"1989","unstructured":"Ugorski, M., Pahlsson, P., Dus, D., Nilsson, B. & Radzikowski, C. Glycosphingolipids of human urothelial cell-lines with different grades of transformation. Glycoconj. J. 6(3), 303\u2013318 (1989).","journal-title":"Glycoconj. J."},{"key":"42260_CR29","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele, W. & Stegner, H. E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8, 138\u2013140 (1987).","journal-title":"Pathologe"},{"issue":"1","key":"42260_CR30","first-page":"83","volume":"20","author":"P Dziegiel","year":"2005","unstructured":"Dziegiel, P., Salwa-Zurawska, W., Zurawski, J., Wojnar, A. & Zabel, M. Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol. Histopathol. 20(1), 83\u201389 (2005).","journal-title":"Histol. Histopathol."},{"issue":"23","key":"42260_CR31","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1111\/bph.70215","volume":"182","author":"M Posta","year":"2025","unstructured":"Posta, M. & Gyorffy, B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br. J. Pharmacol. 182(23), 5734\u20135747 (2025).","journal-title":"Br. J. Pharmacol."},{"issue":"7418","key":"42260_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490(7418), 61\u201370 (2012).","journal-title":"Nature"},{"issue":"3","key":"42260_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/B:BREA.0000014042.54925.cc","volume":"83","author":"M Lacroix","year":"2004","unstructured":"Lacroix, M. & Leclercq, G. Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res. Treat. 83(3), 249\u2013289 (2004).","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"42260_CR34","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1242\/dev.125.11.2063","volume":"125","author":"M Grigoriou","year":"1998","unstructured":"Grigoriou, M., Tucker, A. S., Sharpe, P. T. & Pachnis, V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development. Development 125(11), 2063\u20132074 (1998).","journal-title":"Development"},{"issue":"36","key":"42260_CR35","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1038\/sj.onc.1209509","volume":"25","author":"MRH Est\u00e9cio","year":"2006","unstructured":"Est\u00e9cio, M. R. H. et al. LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene 25(36), 5018\u20135026 (2006).","journal-title":"Oncogene"},{"key":"42260_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.366","volume":"4","author":"WB Liu","year":"2013","unstructured":"Liu, W. B. et al. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer. Cell Death Dis. 4, 4 (2013).","journal-title":"Cell Death Dis."},{"issue":"13","key":"42260_CR37","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.7150\/jca.19972","volume":"8","author":"JT Yang","year":"2017","unstructured":"Yang, J. T. et al. LHX6, an independent prognostic factor, inhibits lung adenocarcinoma progression through transcriptional silencing of \u03b2-catenin. J. Cancer 8(13), 2561\u20132574 (2017).","journal-title":"J. Cancer"},{"issue":"3","key":"42260_CR38","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.3892\/mmr.2015.3997","volume":"12","author":"Z Hu","year":"2015","unstructured":"Hu, Z. & Xie, L. L. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt\/\u03b2-catenin signaling pathway. Mol. Med. Rep. 12(3), 4634\u20134639 (2015).","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"42260_CR39","first-page":"3067","volume":"22","author":"QJ Bi","year":"2018","unstructured":"Bi, Q. J., Men, X. J., Han, R. & Li, G. L. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K\/Akt\/mTOR signaling pathway. Eur. Rev. Med. Pharmacol. 22(10), 3067\u20133073 (2018).","journal-title":"Eur. Rev. Med. Pharmacol."},{"issue":"6","key":"42260_CR40","first-page":"3147","volume":"35","author":"S Comsa","year":"2015","unstructured":"Comsa, S., C\u00eempean, A. M. & Raica, M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res. 35(6), 3147\u20133154 (2015).","journal-title":"Anticancer Res."},{"key":"42260_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-63","volume":"13","author":"C Gest","year":"2013","unstructured":"Gest, C. et al. Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: Differences in MDA-MB-231 and MCF-7 breast cancer cell lines. BMC Cancer 13, 13 (2013).","journal-title":"BMC Cancer"},{"issue":"8","key":"42260_CR42","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/1087057112449863","volume":"17","author":"DF Quail","year":"2012","unstructured":"Quail, D. F., Maciel, T. J., Rogers, K. & Postovit, L. M. A unique 3D in vitro cellular invasion assay. J. Biomol. Screen. 17(8), 1088\u20131095 (2012).","journal-title":"J. Biomol. Screen."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42260-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:02:37Z","timestamp":1775836957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42260-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42260"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42260-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11934"}}